- IFF (NYSE: IFF) Pharma Solutions to exhibit at Vitafoods™ Europe 2025, showcasing plant-based dietary supplement ingredients.
- Event scheduled from May 20-22, 2025, at Fira Barcelona Gran Via, booth 4F25.
- Highlighting innovative brands such as SeaGel®, VERDIGEL™ SC, GRINDSTED® Pectin Premium, and METHOCEL™.
IFF (NYSE: IFF) Pharma Solutions has announced its participation in Vitafoods™ Europe 2025, where it will feature its range of innovative plant-based dietary supplement ingredients. The event is slated for May 20-22 at the Fira Barcelona Gran Via, booth 4F25. This premier global nutraceutical event provides an ideal platform for IFF to demonstrate its technical expertise and commitment to the dietary supplement industry.
The showcase will include several high-performance products such as SeaGel®, VERDIGEL™ SC, GRINDSTED® Pectin Premium, Ac-Di-Sol®, Avicel®, Accelerate®, and METHOCEL™. These products offer diverse solutions including vegan softgels, plant-based gummies, and tablet binders and disintegrants, emphasizing the company's dedication to clean-label and non-GMO solutions.
Firat Nalbantoglu, EMEA Commercial Leader at IFF Pharma Solutions, expressed excitement about the event, saying, "Our high-quality functional ingredients and technical expertise help our customers produce superior supplements. We look forward to offering solutions for formulation and processing challenges."
Key products such as SeaGel® and VERDIGEL™ SC are highlighted as plant-based alternatives to gelatin, providing superior quality and performance for vegan softgels. Meanwhile, Avicel® serves as a cellulose-based tablet binder and filler, ensuring efficient tablet production with enhanced stability in liquid formulations.
Overall, IFF is set to showcase its advancements in dietary supplements through an array of high-performance, plant-based ingredients and reliable technology during this key event in the nutraceutical sector.
